Literature DB >> 33189035

Virus-like hollow mesoporous silica nanoparticles for cancer combination therapy.

Dajun Xu1, Xiaoxiao Song2, Jiahong Zhou2, Xueliang Ouyang1, Jinping Li1, Dawei Deng3.   

Abstract

Virus-like nanostructures could involve their interaction with biological hosts, as well as adaptive immune responses. Herein, imitating the intrinsic structure of virus, we formulated novel virus-like hollow mesoporous silica nanoparticles (VH-MSNs) by using self-consuming perovskite template. The unique topological structure on the surface of nanoparticles could enhance cellular uptake and amplify the immune response. By loading doxorubicin (DOX) on nanoparticles, we achieved a combination of chemotherapy and immunotherapy. This study provides a promising platform with superior cellular uptake property for drug delivery and a basis for the study of the effect of surface physical structure on the nanocarriers.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer combination therapy; Mesoporous silica; Perovskite template; Virus-like

Mesh:

Substances:

Year:  2020        PMID: 33189035     DOI: 10.1016/j.colsurfb.2020.111452

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  3 in total

Review 1.  Recent Advances of Mesoporous Silica as a Platform for Cancer Immunotherapy.

Authors:  Albert Yu; Xiaoyong Dai; Zixian Wang; Huaqing Chen; Bing Guo; Laiqiang Huang
Journal:  Biosensors (Basel)       Date:  2022-02-10

2.  Flower-like Composite Material Delivery of Co-Packaged Lenvatinib and Bufalin Prevents the Migration and Invasion of Cholangiocarcinoma.

Authors:  Zhouyu Ning; Yingke Zhao; Xia Yan; Yongqiang Hua; Zhiqiang Meng
Journal:  Nanomaterials (Basel)       Date:  2022-06-15       Impact factor: 5.719

Review 3.  Mesoporous Silica Materials as an Emerging Tool for Cancer Immunotherapy.

Authors:  Blanca Escriche-Navarro; Andrea Escudero; Elena Lucena-Sánchez; Félix Sancenón; Alba García-Fernández; Ramón Martínez-Máñez
Journal:  Adv Sci (Weinh)       Date:  2022-07-22       Impact factor: 17.521

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.